Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
Cancer Research|October 15, 1995
Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell linesN Borsellino, A Belldegrun, B BonavidaSeminars in Urologic Oncology|May 17, 2001
Biology of renal cell carcinoma: changing concepts in classification and stagingA J Pantuck, A Zisman, A BelldegrunThe Journal of Urology|January 1, 1988
Anti-tumor reactivity of human lymphokine activated killer (LAK) cells against fresh and cultured preparations of renal cell cancerA Belldegrun, I Uppenkamp, S A RosenbergInternational Journal of Urology : Official Journal of the Japanese Urological Association|July 10, 2001
Gene and immune therapy for renal cell carcinomaA J Pantuck, A Zisman, A BelldegrunThe Journal of Urology|May 1, 1993
Sensitivity of human renal cell carcinoma lines to TNF, adriamycin, and combination: role of TNF mRNA induction in overcoming resistanceJ T Safrit, A Belldegrun, B BonavidaThe Cancer Journal From Scientific American|February 24, 2000
Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinomaA Belldegrun, O Shvarts, R A FiglinSeminars in Urologic Oncology|November 1, 1996
Renal cell carcinoma: basic biology and clinical behaviorJ R Franklin, R Figlin, A BelldegrunReviews in Urology|September 21, 2006
Immune and genetic therapies for advanced renal cell carcinomaA Zisman, A J Pantuck, A BelldegrunThe Prostate|August 10, 1999
Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesisP J Frost, A Belldegrun, B BonavidaCancer Research|January 1, 1988
Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activityA Belldegrun, L M Muul, S A RosenbergPageof 11